Nuvectis Pharma
NVCT
NVCT
41 hedge funds and large institutions have $7.63M invested in Nuvectis Pharma in 2024 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
40% less capital invested
Capital invested by funds: $12.8M → $7.63M (-$5.18M)
Holders
41
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$506K | |
| 2 | +$390K | |
| 3 | +$147K | |
| 4 |
Jane Street
New York
|
+$108K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$94.6K |
Top Sellers
| 1 | -$1.83M | |
| 2 | -$722K | |
| 3 | -$515K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$302K |
| 5 |
Morgan Stanley
New York
|
-$196K |